DROSHA and neoplasm: Overall, our data suggest that in a fraction of relapsing WT patients SIX1 and DROSHA mutations might be (whether spatially or temporally) heterogeneous events within the primary tumor, which are positively selected in the process of tumor progression to recurrence.